101 related articles for article (PubMed ID: 1967858)
21. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
22. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.
Pirsch JD; Stratta RJ; Sollinger HW; Hafez GR; D'Alessandro AM; Kalayoglu M; Belzer FO
Am J Med; 1989 Feb; 86(2):241-4. PubMed ID: 2536518
[No Abstract] [Full Text] [Related]
23. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
Cohen JI
Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
[TBL] [Abstract][Full Text] [Related]
24. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.
Kuo PC; Dafoe DC; Alfrey EJ; Sibley RK; Scandling JD
Transplantation; 1995 Jan; 59(1):135-8. PubMed ID: 7839414
[No Abstract] [Full Text] [Related]
26. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
[TBL] [Abstract][Full Text] [Related]
27. Overview of posttransplant B-cell lymphoproliferative disorders.
Swinnen LJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
[TBL] [Abstract][Full Text] [Related]
28. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
30. Isolated central nervous system Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Watanabe A; Yoshida S; Kasahara Y; Takachi T; Ogawa A; Asami K
Pediatr Blood Cancer; 2011 May; 56(5):871-2. PubMed ID: 21370426
[No Abstract] [Full Text] [Related]
31. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
Hidalgo M; Lumbreras C; Aguado JM
Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
[No Abstract] [Full Text] [Related]
32. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
Petrovic LM
Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
[No Abstract] [Full Text] [Related]
33. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
Börcek P; Özdemir BH; Özgün G; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated lymphoproliferative disorder. Applications of immunoperoxidase and molecular biologic techniques.
Kornstein MJ; Weber J; Luck JB; Massey GV; Strom S; McWilliams NB
Arch Pathol Lab Med; 1989 May; 113(5):481-4. PubMed ID: 2540726
[TBL] [Abstract][Full Text] [Related]
35. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
36. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern.
Malatack JF; Gartner JC; Urbach AH; Zitelli BJ
J Pediatr; 1991 May; 118(5):667-75. PubMed ID: 1850458
[TBL] [Abstract][Full Text] [Related]
37. [Lymphoproliferative syndrome induced by Epstein-Barr virus after kidney transplantation: value of genotypic analysis].
Dussol B; Bernard O; Xerri L; Stoppa AM; Brunet P; Maraninchi D; Berland Y
Presse Med; 1995 Jun; 24(22):1033-5. PubMed ID: 7667231
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients.
Sokal EM; Caragiozoglou T; Lamy M; Reding R; Otte JB
Transplantation; 1993 Dec; 56(6):1394-8. PubMed ID: 8279009
[TBL] [Abstract][Full Text] [Related]
39. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
